After Recall, Duckworth Calls on FTC to Investigate Formula Manufacturer ByHeart's Refund Policy

WASHINGTON, D.C. – U.S. Senator Tammy Duckworth (D-IL) is calling on the Federal Trade Commission (FTC) to open an investigation into whether the refund policy of infant formula manufacturer ByHeart is unfair and deceptive, advocating for families to get the full refund they deserve. Earlier this month, all ByHeart Whole Nutrition Infant Formula products were recalled due to the U.S. Food and Drug Administration (FDA)’s ongoing outbreak investigation of infant botulism—a serious medical condition that can be fatal. In a letter to FTC Chairman Andrew Ferguson, Duckworth highlights that despite this sweeping recall, ByHeart’s policy fails to fully reimburse families, only refunding up to two units of ByHeart products purchased on or after October 1.“Customers who purchased far more than two